Fresenius Medical Care AG & Co. KGaA

  • WKN: 578580
  • ISIN: DE0005785802
  • Land: Deutschland

Nachricht vom 01.11.2019 | 15:22

Fresenius Medical Care AG & Co. KGaA: Release according to Article 50 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Fresenius Medical Care AG & Co. KGaA / Third country release according to Article 50 Para. 1, No. 2 of the WpHG [the German Securities Trading Act]

01.11.2019 / 15:22
Dissemination of a Post-admission Duties announcement according to Article 50 Para. 1, No. 2 WpHG transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Fresenius Medical Care AG & Co. KGaA has filed amendments to its Form 20-F report for the fiscal year 2018, its Form 6-K report for the first quarter of 2019 and its Form 6-K report for the second quarter of 2019 with the U.S. Securities and Exchange Commission. The reports are available on the Company's website at https://www.freseniusmedicalcare.com/en/investors/news-publications/financial-reports/.


01.11.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

Event im Fokus

Fachkonferenz Beteiligungsgesellschaften, 15.07.2020

Fachkonferenz Consumer / Leisure, 16.07.2020

Die Konferenzen finden aufgrund der aktuellen Situation nicht in den Räumen der Börse München statt, sondern als Online-Konferenz.

News im Fokus

BASF SE: BASF-Gruppe: operatives Ergebnis im 2. Quartal 2020 über Markterwartungen; Ergebnis nach Steuern und nicht beherrschenden Anteilen infolge einer vor allem öl- und gaspreisbedingten Wertberichtigung der Beteiligung Wintershall Dea unter Markterwar

10. Juli 2020, 14:27

Aktuelle Research-Studie

Original-Research: PAION AG (von First Berlin Equity Research GmbH): Kaufen PAION AG

09. Juli 2020